Harnessing Specialized Metabolism from Anaerobes
The AnoxyGen project aims to explore and harness the unique biosynthetic capabilities of anaerobic bacteria to discover novel metabolites and enhance biotechnological applications for health and ecology.
Projectdetails
Introduction
Anaerobic bacteria, a group of microorganisms that thrive in the absence of oxygen, have a significant impact on the quality of life on Earth. They play a crucial role in biotechnology and are essential components of the gut microbiota. As such, they are of tremendous importance for human, animal, and environmental health. On the other hand, certain anaerobes can be life-threatening pathogens.
Need for Understanding Specialized Metabolites
In light of this, there is an urgent need for a deeper understanding of the specialized metabolites of anaerobes, which could function as chemical mediators, virulence factors, and antibiotics. Although genome analyses indicate that anaerobic bacteria hold enormous potential for producing structurally unique compounds, biosynthetic gene clusters are typically downregulated or silent under laboratory conditions.
Challenges in Synthetic Biology
Synthetic biology approaches to unearth these cryptic pathways have been hampered by several challenges:
- Lack of universal activation strategies
- Cumbersome genetic tractability of anaerobes
- Incompatibility of standard expression systems with the oxygen-sensitive biosynthetic enzymes
The AnoxyGen Project
The AnoxyGen project seeks to unearth the vast structural wealth of natural products from the anaerobic world and leverage their unique biosynthetic machinery using a highly versatile anaerobic expression platform. This ambitious initiative comprises four work packages aimed at:
- Refining synthetic biology tools
- Creating gain-of-function anaerobes
- Discovering novel drug candidates and virulence factors
- Engineering biosynthetic pathways to create metabolic diversity
Expected Outcomes
By achieving these objectives, AnoxyGen will grant a comprehensive overview of specialized metabolites and biocatalysts of anaerobes, which have great translational value for medicine, ecology, and biotechnology.
Benefits to Society
In addition to providing valuable methods and tools to the scientific community, this project has the potential to bring significant benefits for the health and well-being of people, animals, and the environment.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.859 |
Totale projectbegroting | € 2.499.859 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-INSTITUTpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
The ANAEROBic treasure trunkANAEROB aims to create a versatile platform for designing microbial consortia to enhance anaerobic processes for upcycling organic waste into sustainable materials and energy. | ERC Advanced... | € 2.494.159 | 2024 | Details |
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demandThis project aims to unlock the expression of cryptic biosynthetic gene clusters in Streptomyces to enhance drug discovery and agricultural applications through innovative systems biology and ecological insights. | ERC Advanced... | € 3.343.206 | 2022 | Details |
Scalable Microbial Metabolite Discovery Through Synthetic BiologyThis project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development. | ERC Starting... | € 1.490.250 | 2024 | Details |
An anaerobic native approach to shine Light on C1-cycling biochemistry using Environmental microbial biomass.EnLightEn aims to characterize uncultured anaerobic archaea and their enzymes using native biomass to uncover their role in carbon cycling and microbial biogeochemistry. | ERC Consolid... | € 2.000.000 | 2024 | Details |
SYNergize: Understanding spore-forming gut bacteria biology to target pathogensSYNergize aims to characterize gut spore-formers to develop synbiotics that inhibit pathogens and combat antimicrobial resistance through enhanced understanding of sporulation and transmission processes. | ERC Starting... | € 1.499.503 | 2024 | Details |
The ANAEROBic treasure trunk
ANAEROB aims to create a versatile platform for designing microbial consortia to enhance anaerobic processes for upcycling organic waste into sustainable materials and energy.
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demand
This project aims to unlock the expression of cryptic biosynthetic gene clusters in Streptomyces to enhance drug discovery and agricultural applications through innovative systems biology and ecological insights.
Scalable Microbial Metabolite Discovery Through Synthetic Biology
This project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development.
An anaerobic native approach to shine Light on C1-cycling biochemistry using Environmental microbial biomass.
EnLightEn aims to characterize uncultured anaerobic archaea and their enzymes using native biomass to uncover their role in carbon cycling and microbial biogeochemistry.
SYNergize: Understanding spore-forming gut bacteria biology to target pathogens
SYNergize aims to characterize gut spore-formers to develop synbiotics that inhibit pathogens and combat antimicrobial resistance through enhanced understanding of sporulation and transmission processes.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
InnomABsIPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie. | Mkb-innovati... | € 14.888 | 2023 | Details |
Advanced nanomaterials to target genomic and Z-DNA for bacterial biofilm eradicationBactEradiX aims to create a novel antimicrobial nanomaterial targeting biofilm Z-DNA to effectively eradicate chronic infections caused by drug-resistant bacteria. | EIC Pathfinder | € 2.996.312 | 2024 | Details |
InnomABs
IPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie.
Advanced nanomaterials to target genomic and Z-DNA for bacterial biofilm eradication
BactEradiX aims to create a novel antimicrobial nanomaterial targeting biofilm Z-DNA to effectively eradicate chronic infections caused by drug-resistant bacteria.